Detection Markers in Trypanosomiasis
Researchers from Imperial College London and the University of Aberdeen have identified disease markers for Human African Trypanosomiasis (HAT), commonly known as “sleeping sickness”. Using reversed-phase ultrahigh‑performance liquid chromatography coupled to mass spectrometry (UHPLC–MS) and proton nuclear magnetic resonance (1H NMR) spectroscopy researchers found 53 discriminatory metabolite markers.
Photo Credit: Stocktrek Images/Getty Images
Researchers from Imperial College London and the University of Aberdeen have identified disease markers for Human African Trypanosomiasis (HAT), commonly known as “sleeping sickness”.1 Using reversed-phase ultrahigh-performance liquid chromatography coupled to mass spectrometry (UHPLC–MS) and proton nuclear magnetic resonance (1H NMR) spectroscopy researchers found 53 discriminatory metabolite markers.
Sleeping sickness is prominent throughout large portions of Africa causing significant death and disease. Infection is caused by two subspecies of Trypanosoma brucei (T.b.) transmitted via tsetse fly vectors. T.b. gambiense is endemic within Western Africa while T.b. rhodiesiense is more prominent within Eastern and Southern Africa. The latter is typically fatal in less than a year if infection is untreated.
Routine screening and rapid diagnostic tests are available for T.b. gambiense. However, no such test exists for T.b. rhodiesiense, making diagnosis the biggest challenge in the treatment and control of this disease.
To produce an effective diagnostic test researchers required markers that differentiate infected individuals from uninfected individuals to use in diagnostic screening. 1H NMR was used to screen plasma for variant surface glycoproteins (markers). Previous research had highlighted marked changes in plasma lipids in infected individuals.2,3,4 Consequently reversed-phase UHPLC–MS was used to characterize lipid profiles.
Large variations were found in plasma profiles, specifically in lipid and amino acids, through both 1H NMR and reversed-phase UHPLC–MS. Sixteen disease markers were identified by NMR while UHPLC identified a further 37 markers. The authors hope these markers can be used to create a novel and rapid screening procedure for T.b. rhodiesiense. - L.B.
References
- Lamour et al., PLoS Negl. Trop. Dis. 9(10), e0004200 (2015).
- Wang et al., Proc. Natl. Acad. Sci. USA 105, 6127–6132 (2008).
- Rouzer and Cerami, Mol. Biochem. Parasitol. 2, 31–38 (1980).
- Nakamura, Vet. Parasitol. 80, 117–125 (1998).
Liquid Chromatography to Analyze Vitamin D Proteins in Psoriasis Patients
January 21st 2025Can a protein involved in delivering Vitamin D to target tissues have an altered serum profile in psoriasis patients with cardiovascular disease? Researchers used liquid chromatography (LC) to help find out.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
